APA (7th ed.) Citation

AP, N., DL, H., DA, T., PK, M., JR, W., ME, L., . . . MF, P. (2026). Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio. Clinical pharmacology and therapeutics, 119(6), 1485. https://doi.org/10.1002/cpt.70218

Chicago Style (17th ed.) Citation

AP, Nguyen, Hadi DL, Todd DA, Manwill PK, White JR, Layton ME, Cech NB, Thummel KE, and Paine MF. "Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio." Clinical Pharmacology and Therapeutics 119, no. 6 (2026): 1485. https://doi.org/10.1002/cpt.70218.

MLA (9th ed.) Citation

AP, Nguyen, et al. "Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio." Clinical Pharmacology and Therapeutics, vol. 119, no. 6, 2026, p. 1485, https://doi.org/10.1002/cpt.70218.